Besides, it induces protein phosphatase 2A inactivation and tau hyperphosphorylation through the Src-dependent pathway, leading to a net increase in phosphorylated tau that may exacerbate AD-like tau pathologies [92, 93]. The gene discussed is MAPT; the disease is Alzheimer disease.